XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Awards and Restricted Stock Grants

A summary of stock option awards and restricted stock grants, inclusive of awards granted under the 2018 Stock Plan and Inducement Option Grants for the nine-months ended September 30, 2022 is presented below:

 

   Stock Options   Restricted Stock Awards  

Weighted

Average

 
  

Options

Outstanding

  

Weighted

Average

Exercise

Price

  

Non-vested

Restricted

Stock

Outstanding

  

Weighted

Average

Grant

Date

Fair Value

  

Contractual

Terms of

Equity

Awards

(in years)

 
Equity awards outstanding at January 1, 2022   441,425   $38.50    1,481   $12.36      
                          
Equity awards granted   697,156   $2.79    55,650   $1.96      
                          
Equity awards terminated   (17,659)  $35.28    (100)  $9.45      
                          
Equity awards outstanding at September 30, 2022   1,120,922   $16.33    57,031   $2.23    8.1 
                          
Aggregate intrinsic value of outstanding equity awards at September 30, 2022  $335        $-           
                          
Equity awards exercisable at September 30, 2022   521,723   $27.72              7.5 
                          
Aggregate intrinsic value of equity awards exercisable at September 30, 2022  $-                     
Schedule of Assumptions Used to Determine Fair Value of Options Granted

 

    

For the Nine Months Ended

September 30,

 
    2022    2021 
Risk-free interest rate   1.74 to 4.14%   1.54 to 1.74%
Expected volatility   107.6 to 113.95%   106.8 to 113.2%
Expected life (in years)   7.5 to 9.0    7.5 to 10.0 
Expected dividend yield   -%   -%